661 computer-science-quantum "https:" "https:" "https:" "https:" "https:" "University of Waterloo" positions at University of Pennsylvania
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of the laboratory. The ideal candidate should have a strong background in biology, bioengineering, and/or molecular biology. Experience with in vitro and in vivo gene editing and/or gene therapy is highly
-
. 2020;117:13730-13739). The lab takes a multidisciplinary approach involving biochemistry, molecular biology, virology, and cell biology. We are seeking enthusiastic and highly motivated researcher to join
-
transactional and reporting activities. Other duties as assigned. Qualifications Bachelor of Science and 5 to 7 years of experience or equivalent combination of education and experience is required. Preferred
-
, mammalian systems. He/she should have computational background for high-dimensional protein expression, RNA sequencing, and TCR sequencing data analyses. The research specialist will enjoy a high level of
-
connection with the legal adoption of an eligible child, such as travel or court fees, for up to two adoptions in your household. To learn more, please visit: https://www.hr.upenn.edu/PennHR/benefits-pay
-
, for up to two adoptions in your household. To learn more, please visit: https://www.hr.upenn.edu/PennHR/benefits-pay
-
B Bachelor of Science and 2 to 3 years of experience or equivalent combination of education and experience is required. Regulatory experience is preferred; Radiation Oncology experience is preferred
-
of Science, Bachelor of Arts, and 7 to 10 years of experience or equivalent combination of education and experience is required. Job Location - City, State Philadelphia, Pennsylvania Department / School
-
assigne CONTINGENT UPON FUNDING Qualifications Bachelor of Science and 1 to 2 years of experience or equivalent combination of education and experience is required. Effective problem solving abilities
-
funded clinical and non-clinical research projects, including early phase, complex clinical trials and large federal grants, supporting a robust research program studying patients with rare early-onset